Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport. (Q39441258)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Alzheimer's disease

0 references

Céline Héraud

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jean-Pierre Brion

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Marina Morel

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Charles Nicaise

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Valérie Suain

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

18 November 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Acta Neuropathologica

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

123

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

71-84

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22094641%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

https://scigraph.springernature.com/pub.10.1007/s00401-011-0901-4

0 references

Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

The selectivity of protein kinase inhibitors: a further update

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Advances in cytochemical methods for detection of apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

A novel brain ATPase with properties expected for the fast axonal transport motor

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Axon degeneration mechanisms: commonality amid diversity

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Role of axonal transport in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Differential regulation of dynein and kinesin motor proteins by tau

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Synaptic loss in Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

The axonal transport of mitochondria.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

The GSK3 hypothesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Aging attenuates dynactin-dynein interaction: down-regulation of dynein causes accumulation of endogenous tau and amyloid precursor protein in human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Alternatively spliced products of the human kinesin light chain 1 (KNS2) gene

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Glycogen synthase kinase-3beta and the p25 activator of cyclin dependent kinase 5 increase pausing of mitochondria in neurons

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Tau binding to microtubules does not directly affect microtubule-based vesicle motility.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Axonal transport defects in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Life and death of neurons in the aging brain

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Cytoplasmic dynein nomenclature

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Two kinesin light chain genes in mice. Identification and characterization of the encoded proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Unloading kinesin transported cargoes from the tubulin track via the inflammatory c-Jun N-terminal kinase pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells: The effects on the organization and stability of microtubules

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0901-4

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39441258&oldid=1458802400"